1-3 of 3
Ryan J Castoro
Close
Sort by
Journal Articles

Final Report of a Randomized Study of Decitabine Versus Conventional Care (CC) for Maintenance Therapy in Patients with Intermediate and High Risk Acute Myeloid Leukemia (AML) in First or Subsequent Complete Remission (CR)

Yanis Boumber, MD, PhD, Jean-Pierre Issa, MD, Jeffrey L. Jorgensen, MD, PhD, Stefan Faderl, MD, Ryan J Castoro, Jane Autry, Guillermo Garcia-Manero, Gautam Borthakur, Elias Jabbour, Zeev Estrov, Jorge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi, MD
Journal: Blood
Blood (2011) 118 (21): 1530.
https://doi.org/10.1182/blood.V118.21.1530.1530
Published: 2011
Journal Articles

DNA Methylation and Gene Expression Analysis in a Phase II Randomized Study of Decitabine Vs. Decitabine Plus Valproic Acid in MDS and AML.

Ryan J Castoro, Noel J Raynal, Ph.D., Xuelin Huang, Ph.D., Carlos E. Bueso-Ramos, M.D., Ph.D, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Jean-Pierre J Issa, MD
Journal: Blood
Blood (2009) 114 (22): 3808.
https://doi.org/10.1182/blood.V114.22.3808.3808
Published: 2009
Journal Articles

Microrna 124 and Its Role in Response to Epigenetic Therapy in Patients with Acute Mylogenous Leukemia and Myelodysplastic Syndrome

Ryan J Castoro, Mhair Dekmezian, Amanda J Saraf, Yoshiyuki Watanabe, Woonbok Chung, Samih El Adhab, Jaroslav Jelinek, Jean-Pierre Issa, MD
Journal: Blood
Blood (2008) 112 (11): 598.
https://doi.org/10.1182/blood.V112.11.598.598
Published: 2008